BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21297446)

  • 1. Pdx1 expression in pancreatic precursor lesions and neoplasms.
    Park JY; Hong SM; Klimstra DS; Goggins MG; Maitra A; Hruban RH
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):444-9. PubMed ID: 21297446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms.
    Shroff S; Rashid A; Wang H; Katz MH; Abbruzzese JL; Fleming JB; Wang H
    Hum Pathol; 2014 Mar; 45(3):456-63. PubMed ID: 24418153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance.
    Roy N; Takeuchi KK; Ruggeri JM; Bailey P; Chang D; Li J; Leonhardt L; Puri S; Hoffman MT; Gao S; Halbrook CJ; Song Y; Ljungman M; Malik S; Wright CV; Dawson DW; Biankin AV; Hebrok M; Crawford HC
    Genes Dev; 2016 Dec; 30(24):2669-2683. PubMed ID: 28087712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
    Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
    Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of cdx2 homeobox gene in intraductal papillary-mucinous neoplasm of the pancreas but not in pancreatic ductal adenocarcinoma.
    Yeh TS; Ho YP; Chiu CT; Chen TC; Jan YY; Chen MF
    Pancreas; 2005 Apr; 30(3):233-8. PubMed ID: 15782100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
    Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
    Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer.
    Ohya A; Yamanoi K; Shimojo H; Fujii C; Nakayama J
    Cancer Sci; 2017 Sep; 108(9):1897-1902. PubMed ID: 28685935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
    Shi C; Hong SM; Lim P; Kamiyama H; Khan M; Anders RA; Goggins M; Hruban RH; Eshleman JR
    Mol Cancer Res; 2009 Feb; 7(2):230-6. PubMed ID: 19208745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms.
    Chang X; Yu C; Li J; Yu S; Chen J
    Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816
    [No Abstract]   [Full Text] [Related]  

  • 12. Activated wnt signaling in stroma contributes to development of pancreatic mucinous cystic neoplasms.
    Sano M; Driscoll DR; De Jesus-Monge WE; Klimstra DS; Lewis BC
    Gastroenterology; 2014 Jan; 146(1):257-67. PubMed ID: 24067880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.
    Ettel M; Zhao L; Schechter S; Shi J
    Pathology; 2019 Jun; 51(4):392-398. PubMed ID: 31060750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
    Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
    Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
    Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
    Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Int J Cancer; 2007 Apr; 120(8):1634-40. PubMed ID: 17236203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic DCLK1
    Qiu W; Remotti HE; Tang SM; Wang E; Dobberteen L; Lee Youssof A; Lee JH; Cheung EC; Su GH
    Cancer Lett; 2018 Jun; 423():71-79. PubMed ID: 29526803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gli2 protein expression level is a feasible marker of ligand-dependent hedgehog activation in pancreatic neoplasms.
    Sugiyama Y; Sasajima J; Mizukami Y; Koizumi K; Kawamoto T; Ono Y; Karasaki H; Tanabe H; Fujiya M; Kohgo Y
    Pol J Pathol; 2016 Jun; 67(2):136-44. PubMed ID: 27543868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.
    Gold DV; Karanjawala Z; Modrak DE; Goldenberg DM; Hruban RH
    Clin Cancer Res; 2007 Dec; 13(24):7380-7. PubMed ID: 18094420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
    Fukuda A
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.